"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...

The study also leveraged advanced diagnostic tools to identify early biomarkers of cognitive decline in individuals with a ...

The results of a recent study suggest that people with a weaker or more irregular body clock, also known as circadian rhythm, ...

Scientists behind the study say that if the harmful influence of the gene could be neutralised, up to three-quarters - and ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

One gene called APOE has long been known to increase the risk of Alzheimer’s disease, but without a specific variant most ...

A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice.  Researchers ...

Routine vaccinations offered to adults may help protect against dementia, recent research has shown.

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...